Neuronetics (STIM) reported a quarterly loss of $0.39 per share, beating the Zacks Consensus Estimate of a loss of $0.43. Revenues were $16.33 million, exceeding expectations by 6.27%. Neuronetics has outperformed the market, but future stock performance depends on earnings outlook, which is currently rated as a Hold by Zacks Rank #3.

Sight Sciences, Inc. (SGHT) is expected to report a quarterly loss of $0.46 per share, with revenues expected to be $16.22 million, up 29.3% from last year. The company’s consensus EPS estimate has been revised 3.1% higher in the last 30 days. Investors can track earnings estimate revisions using tools like Zacks Rank for insights into stock performance.

The electric vehicle (EV) industry presents opportunities for investors as the EV revolution continues to gain momentum. Zacks’ Special Report highlights 5 EV stocks with extreme upside potential for investors looking to capitalize on future technologies in the industry. For the latest recommendations from Zacks Investment Research, download the 7 Best Stocks for the Next 30 Days report.

Read more at Nasdaq: Neuronetics (STIM) Reports Q2 Loss, Tops Revenue Estimates